Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Adhera Therapeutics Inc (ATRX)

Adhera Therapeutics Inc (ATRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adhera Therapeutics Inc 8000 INNOVATION PARKWAY BATON ROUGE LA 70820 USA

www.adherathera.com P: 919-518-3748

Description:

Adhera Therapeutics Inc. is a bio-technology company. It researches and develops therapies for the treatment of inflammatory diseases, hyper-tension and cancer. The company's product pipeline consists of PRESTALIA(R) and DyrctAxess which are in clinical stage. Adhera Therapeutics Inc., formerly known as Marina Biotech Inc., is based in Durham, United States.

Key Statistics

Overview:

Market Capitalization, $K 152
Enterprise Value, $K 8,712
Shares Outstanding, K 11,079
Annual Sales, $ 0 K
Annual Net Income, $ -2,110 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -3,540 K
EBIT, $ -1,280 K
EBITDA, $ 530 K
60-Month Beta -0.11
% of Insider Shareholders 28.20%
% of Institutional Shareholders 0.00%
Float, K 7,955
% Float 71.80%
Short Volume Ratio 0.50

Growth:

1-Year Return -97.60%
3-Year Return -99.24%
5-Year Return -99.80%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.83 on 11/20/23
Latest Earnings Date 03/29/24 [--]
Earnings Per Share ttm -1.15
EPS Growth vs. Prev Qtr -8,200.00%
EPS Growth vs. Prev Year -45.61%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 10/06/22

ATRX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -5,805.73%
Profit Margin % 0.00%
Debt/Equity -0.37
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -4.02
Interest Coverage -0.57
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar